PharmaBoardroom

Michael Chan – Senior Vice President, Global Issuer…

Michael Chan, Senior Vice President of Global Issuer Services for the Hong Kong Exchange (HKEX) highlights the vibrancy and diversity that biotechs…

Updates on Drug Distribution Regulation in Brazil

For more than 20 years, Ordinance No. 802/1998 ("Ordinance No. 802/1998"), issued by the Brazilian Ministry of Health, used to regulate the…

Top Drugs Globally in 2019 by Sales

The world's bestselling treatments for 2019 by sales in USD billions. AbbVie's Humira is out in front with USD 19.7 billion in sales, followed by…

Japan New Drug Approvals 2019

A comprehensive list of the new drugs approved by Japan's Pharmaceutical and Medical Devices Agency (PMDA) in 2019. Made with Visme Infographic…

Top 10 Pharma Companies in Mexico

A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. Four of the top…

UK Pharma News Roundup May 2020

Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British intensive care units (ICUs),…

Top 10 Pharma Companies in Japan

Below we highlight the top 10 pharma companies in Japan based on data for 2019 sales of ethical drugs in USD billions. Japanese firms Takeda and…

Pharma Faces: Mouloud Boukhachab, Pierre Fabre MEA

Mouloud Boukhachab, Pierre Fabre’s managing director for Africa, the Middle East and Turkey, took on the new responsibilities of his current…

Speeding up the Search for Safe & Effective COVID-19…

IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…

Omar Lugo Aguirre – Country Lead, nPVU & Market…

UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas around neurodegenerative and mental…

Pharma Faces: Carol Lynch, Sandoz US

Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom about how her diverse global…

Chinese Biotechs’ Domestic Pricing Strategies

Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent successful IPOs, are increasingly…

Sign in

Tagged with